COMMUNIQUÉS West-GlobeNewswire

New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma
29/05/2026
MajesTEC-9 is the second positive Phase 3 study to reinforce the strength of Johnson & Johnson’s TECVAYLI ® as early as second line 1 TECVAYLI ® delivered deep and durable responses, with nearly two-thirds of [...]
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
29/05/2026
Data will highlight deeper mechanistic insights and long-term dosing potential of SAB-142, a fully human multi-specific ATG for newly diagnosed Stage 3 T1D MIAMI, May 29, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, [...]
Seer Files ITC Complaint Against Nanomics
29/05/2026
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations REDWOOD CITY, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased [...]
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
29/05/2026
New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
29/05/2026
ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
29/05/2026
Ghent, Belgium, May 29, 2026 (GLOBE NEWSWIRE) -- Post-hoc analysis from the POSEIDON study demonstrates long-term resolution of ascites and early signs of liver function recovery in over 20% of patients with alfapump in [...]
Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk
29/05/2026
Gumitide Gummies Scam or Legit: Apple Cider Vinegar and BHB Keto Weight Management Formula, Ingredients, Results, and Refund Terms Explained Largo, FL, May 28, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Apogee Therapeutics to Participate in Upcoming June Conferences
28/05/2026
SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences. Jefferies Global [...]
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
29/05/2026
ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and lower rates of hospitalization, emergency department visits, and mortality among nursing facility residents Washington, DC, May [...]
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
28/05/2026
Online TRT Blood Work Through LabCorp and Quest Diagnostics, Sublingual 4-in-1 ED Medication, Prescription Access, and Pricing Explained Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not [...]
OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
28/05/2026
First step of a global financing strategy, as the Company is actively engaging with institutional investors in the United States and in Europe Gross proceeds could amount to €19.3 million based on current share price 1 [...]
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/05/2026
RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026
28/05/2026
Two virtual posters accepted exploring rejections in oncology marketing applications and real-world pulmonary safety of T-DXd in HER2-positive metastatic breast cancer From Insights to Life campaign reinforces Parexel’s [...]
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]
San Antonio Authentic Counseling Expands Veteran Mental Health Accessibility Efforts in Military City USA
28/05/2026
Founded by veteran therapist Steven Flint, LCSW, the San Antonio practice is raising awareness about the growing demand for faster, more accessible therapy resources for veterans and military families. San Antonio, TX, [...]
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
28/05/2026
Inmazeb ® (a three-antibody cocktail consisting of maftivimab, atoltivimab and odesivimab-ebgn) was the first Ebola treatment approved by the U.S. Food and Drug Administration, indicated specifically for the [...]
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
28/05/2026
GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a contract modification valued at approximately $64.5 million from the Administration for [...]
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
28/05/2026
Increases Repurchase Program by $1.0 Billion Highlights of the first quarter include: Net income increased 29% to $69.4 million , and net income margin increased to 20% from 16% last year. Adjusted EBITDA increased 17% [...]
Fortis Life Sciences enrichit son portefeuille AbNano® avec la première bibliothèque VHH dérivée de cellules tueuses naturelles périphériques pour accélérer la découverte d’anticorps
28/05/2026
La nouvelle bibliothèque AbNano® facilite la découverte de VHH dirigés contre des cibles complexes associées aux cellules NK, au service des plateformes de cellules modifiées et de la recherche translationnelle BOSTON, [...]

Pages